Bradlee David Germain

1 Patent

• US118846242024

  Difluorolactam Compounds as EP4 Receptor-selective Agonists for Use in the Treatment of Ep4-mediated Diseases and Conditions

  CAYMAN CHEMICAL COMPANY, Inc.

  0 cites